Secondary Logo

Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy: Erratum

doi: 10.1097/01.aids.0000530853.88590.a9
Errata
Free

The superscript letters to mark the affiliations of four authors viz. Cecilia Moorec, Janaki Amina,d, Paul Penteadoj, and Mark Boyda,b were incorrect in this article [1]. The correct superscript lettering should have been Cecilia Mooreb, Janaki Amina,c, Paul Penteadod, and Mark Boyda,j. The full corrected author list is below:

Gwamaka E. Mwasakifwaa, Cecilia Mooreb, Dianne Careya, Janaki Amina,c, Paul Penteadod, Marcelo Lossoe, Poh-Lian Limf, Lerato Mohapig, Jean-Michel Molinah, Brian Gazzardi, David A. Coopera, Mark Boyda,j

aThe Kirby Institute, University of New South Wales, Sydney, Australia, bMRC Clinical Trials Unit, London, UK, cDepartment of Health Systems and Populations, Macquarie University, dDepartment of Clinical Pharmacology, St Vincent's Hospital, Sydney, Australia, eCICAL, Buenos Aires, Argentina, fTan Tock Seng Hospital, Tan Tock Seng, Singapore, gUniversity of Witwatersrand, Johannesburg, South Africa, hHopital Saint-Louis, Paris, France, iSt Stephen's AIDS Trust, London, UK, and jFaculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia.

Back to Top | Article Outline

Reference

1. Mwasakifwa GE, Moore C, Carey D, Amin J, Penteado P, Losso M, et al. Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy. AIDS 2018; 32:357–361.
Copyright © 2018 Wolters Kluwer Health, Inc.